retatrutide considerations Retatrutide is a newer triple agonist (GIP, GLP-1, and glucagon) that is still in clinical trials
Waist circumference reductions were also dose-dependent for Cagrilintide, notably at 1.24.5 mg, exceeding those in the placebo group and approximating the reductions seen with liraglutide 3.0 mg
GHK, which declines with age, has health promoting effects on many tissues such as chondrocytes, liver cells and human fibroblasts, improves wound healing and tissue regeneration (skin, hair follicles, stomach and intestinal linings, boney tissue), increases collagen, decorin, angiogenesis, and nerve outgrowth, possesses anti-oxidant, anti-inflammatory, anti-pain and anti-anxiety effects, increases cellular stemness and the secretion of trophic factors by mesenchymal stem cells
Proc Natl Acad Sci U S A , 109 (41), 1661816623
Administration: Route by intramuscular (IM) or deep subcutaneous (SC) injection
Its administered more like a glutathione-style shot, and the way your body processes it is completely different
